The 2020 Draft Agenda is Live!
Contact us to receive your copy of the full agenda this November.
Key Benefits of Attending:
Networking: Network one-to-one with 350 other key decision makers across multiple perspectives prioritizing NASH. Meet and collaborate with discovery, translational and safety scientists, as well as clinical program and market access leads, and scientists developing innovative preclinical and non-invasive technologies.
Actionable Insights: Hear first-hand how the latest scientific understanding is being applied to pipeline progress enabling you to benchmark your decisions against others in the field and gain innovative foresight to address challenges before you reach them.
Sharing your data: Present your own work to your peers and thought leaders to gain critical and candid feedback that could be pivotal to opening up partnerships and changing the trajectory of your program.
Harmonize your thoughts with the field: With over 170 organizations gathering to present, discuss and share their expectations for NASH you will align your own thinking with that of the rest of the field and identify the niche that gives you maximum return on investment.